Blog Articles

Healthcare is one of the most profitable verticals in payments, and one of the most heavily scrutinized. For payments companies, the hard part is knowing which healthcare merchants are legitimate before the money moves. In this customer spotlight, Mentom Payments’ Alexis Lichterman and LegitScript’s Angela Salter discuss how the Enterprise Referral Partnership helps payments companies certify healthcare merchants at scale, get them processing faster, and turn compliance into a competitive advantage.

For a lot of behavioral health providers, LegitScript means one thing: permission to advertise. But the seal represents more than that, and lately, it can’t always be taken at face value. At the Behavioral Health Tech Conference, LegitScript’s Naomi Moono joined the MasterMined Podcast to answer the questions providers actually ask: who certification answers to, how the gray areas get decided, why the seal now has to be verified, and where certification is headed next.

Regulators no longer stop at manufacturers. They’re looking at marketplaces too, and fines of €200 million and €550 million this year show the cost of waiting. At the Marketplace Risk Global Summit in London, panelists shared how platforms spot regulator priorities, match messy recall notices, enforce with precision, and turn trust and safety into a driver of growth.

AI is moving faster than regulators can write rules, and marketplaces are making tough calls right now. At the Marketplace Risk Global Summit in London, LegitScript hosted a panel on AI-generated images, synthetic content, and the limits of written policy. Read the recap to see how teams can build defensible standards and train AI to enforce them.

Decadent chocolate and wildflower honey: these unassuming confections are the new face of sexual enhancement. FDA testing has found undeclared prescription drug ingredients in several of these products, which can cause dangerous side effects when taken without the guidance of a medical professional. Learn how to spot these illicit products.

The new enforcement discretion policy released by the US Department of Health and Human Services (HHS) marks a shift in the regulatory landscape for peptide compounding. The policy outlines conditions under which FDA intends to exercise enforcement discretion for compounding involving six specific peptide ingredients (BPC-157 acetate, TB-500 acetate, Epitalon acetate, Semax free base, KPV…

Behavioral health providers have more ways to reach patients than ever, and the fastest growing ones aren’t always the biggest spenders. Get key takeaways from our webinar on directories, social media, and alumni networks, including how to build trust, show up with integrity, and take a low-cost first step in each channel.

Compliance requirements and a seamless patient experience are not opposing forces, even if they’re often treated that way. In episode 2 of our Protecting Your Business series, LegitScript sits down with Nick Mortek of Vouched and Steve Sood of Wizlo to walk through what a well-built onboarding stack actually looks like, from identity verification and consent to the gaps that quietly put growing telehealth businesses at risk.

Most telehealth operators assume patient drop-off is a marketing or UX problem. Often, it isn’t. In episode 1 of our Protecting Your Business series, LegitScript sits down with Nick Mortek of Vouched and Steve Sood of Wizlo to unpack where patients actually abandon onboarding, why the instinct to minimize verification can backfire, and how applying the right level of friction at the right moment can improve both conversion and compliance at the same time.

Peptides are having a moment. There’s just one problem: Many of the most popular peptides on the market today are not currently permissible under the existing FDA regulatory framework. This post breaks down where these substances actually stand today and what all of this means for LegitScript-certified businesses operating within the US.

Nicotine products don’t look like nicotine products anymore, and that’s exactly the problem. Novel products are slipping past standard detection, while a backlogged FDA and a patchwork of state rules make consistent enforcement nearly impossible. A panel at Marketplace Risk’s New York conference dug into where the risk is hiding and what platforms can do.

From deepfake product photos to AI-generated NCII, trust and safety teams are facing a threat that shifts faster than most policies can keep up with. At Marketplace Risk’s New York conference, a panel of experts broke down the evasion tactics bad actors are using right now, the gray areas that trip up even experienced teams, and what it actually takes to build a policy that holds up.

Clearing accessibility and privacy compliance doesn’t give a healthcare business a free pass on its advertising. From unsubstantiated claims to tracking pixels that quietly trigger privacy laws, advertising carries its own fast-evolving risks. In episode 3 of our Protecting Your Business series, LegitScript sits down with Michael Williams of Clym to explore where advertising and disclosure scrutiny is headed, and how certification keeps what patients see aligned with the care they actually get.

Most healthcare businesses think privacy starts and ends with HIPAA. But a patchwork of consumer data privacy laws, now on the books in nearly two dozen states, can apply based on where a patient is browsing from, not where the business operates. In episode 2 of our Protecting Your Business series, LegitScript sits down with Michael Williams of Clym to unpack what it actually takes to manage privacy at scale, and why it matters most in behavioral health and addiction treatment.

Many healthcare businesses treat website accessibility as a checkbox: install a widget and move on. But that leaves them exposed to a fast-growing wave of litigation and misses the bigger point. In the first episode of our Protecting Your Business series, LegitScript sits down with Michael Williams of Clym to unpack why accessibility is an ongoing responsibility, and how it connects directly to the transparency patients rely on to make informed decisions about their care.